IBA Introduces AdaPTinsight XR for Proton Therapy

IBA has launched AdaPTinsight XR, an advanced Cone Beam Computed Tomography (CBCT) imaging solution for image-guided proton therapy (IGPT), enhancing visualization and decision-making in cancer treatment. This next-generation imaging capabilities promise improved image quality and support for the Proteus® systems, helping to standardize proton therapy for more cancer indications. AdaPTinsight XR will be showcased at the ESTRO 2026 Annual Congress.